Emerald Bioscience, Inc. (48) | Uncategorized (13)
Recent Contracts
-
Amendment No. 2 to
(Filed With SEC on July 21, 2022)
-
Amendment No. 1 to Plan of Arrangement
(Filed With SEC on June 17, 2022)
-
Skye Support Agreement
(Filed With SEC on May 23, 2022)
-
EHT Support Agreement
(Filed With SEC on May 23, 2022)
-
Notice of Option Amendment
(Filed With SEC on March 28, 2022)
-
Exclusive Sponsored Research Agreement, dated October 12, 2021, by and between the Company and Emerald Health Biotechnology Espaa, S.L
(Filed With SEC on October 15, 2021)
-
Form of Lock-up Agreement
(Filed With SEC on September 28, 2021)
-
Collaborative Research Agreement, dated April 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L
(Filed With SEC on August 6, 2021)
-
Form of Letter Agreement
(Filed With SEC on July 22, 2021)
-
Collaborative Research Agreement, dated January 2021, by and between Skye Bioscience, Inc. and Emerald Health Biotechnology Espaa, S.L
(Filed With SEC on March 2, 2021)
-
Start-Up Agreement, dated as of August 23, 2019, by and between the Company and Novotech
(Filed With SEC on August 27, 2019)
-
Secured Promissory Note, dated December 28, 2017, by Nemus Bioscience, Inc., to Emerald Health Sciences Inc
(Filed With SEC on January 3, 2018)
-
Security Agreement, dated December 28, 2017, by and among Nemus Bioscience, Inc., and Emerald Health Sciences Inc
(Filed With SEC on January 3, 2018)